Men's Health Boston
Chestnut Hill, Massachusetts, 02467, United States
NCT Number: NCT03313635
This is a single-center study intended to evaluate prealbumin (transthyretin), a marker of anabolic metabolism, in men with androgen deficiency (Low-T). There is emerging evidence that prealbumin is an indicator of anabolic, versus catabolic, metabolism, and that lower levels may be associated with hypogonadism.
Looking for future studies?
Notify Me40 year–75 year
Male
Observational
Chestnut Hill, Massachusetts, 02467, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation of prealbumin levels.
Time frame: 1 day
Evaluation of prealbumin levels in subjects presenting for evaluation of possible late onset adult hypogonadism diagnosed with and without Androgen Deficiency (AD)
Beckman Coulter, Inc.
Industry
Prealbumin (Transthyretin) Levels in Men With Low-T
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05964920
Age-Related Sarcopenia, Healthy Aging
Oslo, Norway
View Trial DetailsNCT04983940
Testosterone Deficiency
Miami, Florida, United States
View Trial DetailsNCT05019859
Diet Modification, Endocrine System Diseases
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT03282682
Behavior, Endocrine System Diseases
Bratislava, Slovakia
View Trial Details